[Safety of medicinal products and reporting of adverse drug reactions]
- PMID: 15654675
[Safety of medicinal products and reporting of adverse drug reactions]
Abstract
The authors present the role of reports of adverse drug reactions (ADR) in pharmacotherapy. Worldwide monitoring of ADRs together with the European and Polish pharmacovigilance systems are discussed. Some practical information concerning the report form is described i.e. types of reactions, definition of a serious adverse drug reaction, minimum information for the report validation, handling of reports.
Similar articles
-
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000. Drug Saf. 2011. PMID: 21332243 Review.
-
[Drug safety: from development to clinical use].Antibiot Khimioter. 2006;51(6):15-22. Antibiot Khimioter. 2006. PMID: 17523417 Review. Russian. No abstract available.
-
Veterinary pharmacovigilance in India: A need of hour.Indian J Pharmacol. 2017 Jan-Feb;49(1):2-3. doi: 10.4103/0253-7613.201035. Indian J Pharmacol. 2017. PMID: 28458414 Free PMC article.
-
Adverse drug reaction monitoring in a secondary care hospital in South India.Br J Clin Pharmacol. 2008 Feb;65(2):210-6. doi: 10.1111/j.1365-2125.2007.02993.x. Epub 2007 Jul 27. Br J Clin Pharmacol. 2008. PMID: 17662089 Free PMC article.
-
Patients' role in reporting adverse drug reactions.Expert Opin Drug Saf. 2004 Jul;3(4):363-8. doi: 10.1517/14740338.3.4.363. Expert Opin Drug Saf. 2004. PMID: 15268652 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials